Patent details

Basic Information

Publication number:

EP3114139

PCT Application Number:

IL2015050234

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157149634

PCT Publication Number:

WO2015132790

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ANTI EOTAXIN-2 ANTIBODIES THAT RECOGNIZE ADDITIONAL CCR3-BINDING CHEMOKINES

French Title of Invention:

ANTICORPS CONTRE EOTAXIN-2 RECONNAISSANT DES CHEMOKINES SUPPLEMENTAIRES SE LIANTS À CCR3

German Title of Invention:

ANTI-EOTAXIN-2 ANTIKÖRPER DIE WEITERE CCR3-BINDENDE CHEMOKINE ERKENNEN

SPC Number:

Dates

Filing date:

04/03/2015

Grant date:

15/06/2022

EP Publication Date:

11/01/2017

PCT Publication Date:

11/09/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/06/2022

EP B1 Publication Date:

15/06/2022

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

04/03/2023

Expiration date:

04/03/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

08/06/2022

 

 

Name:

Chemomab Ltd.

Address:

Kiryat Aditim, Building 7, Entrance B, 6158002 Tel Aviv, Israel (IL)

Inventor

Name:

MOR, Adi

Address:

Israel (IL)

Priority

Priority Number:

201461947852 P

Priority Date:

04/03/2014

Priority Country:

United States (US)

Classification

IPC classification:

C07K 16/24; C12N 15/13; A61K 39/395; A61P 37/00;

Publication

European Patent Bulletin

Issue number:

202224

Publication date:

15/06/2022

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages